AnazaoHealth Recalls Compounded Plaquex Intravenous Injection Due to Unapproved Ingredient Source
AnazaoHealth Corporation is recalling 51 vials of Compounded Plaquex intravenous injection nationwide because the product contains an active pharmaceutical ingredient from an unapproved source.
- Product
- Compounded Plaquex, intravenous injection, 50 ML vial. Each ml contains: Phosphatidyl Choline 50 mg, Sodium Deoxycholate 25 mg, Benzyl Alcohol 0.9%, Ethanol (95%) 2.4 mg di Alpha Tocopheryl Acetate 0.2 mg in Sterile Water for injection.
- Category
- Drug
- Distribution
- Distributed nationwide